Publications
5808 Results
- Journal / Conference
- Journal of Clinical Oncology 33:5s (suppl; abstr 4008); American Society of Clinical Oncology Annual Meeting (May 29-June 2, 2015, Chicago, IL), oral;
- Year
- 2015
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- CTSU/A021101
Intergroup pilot study of preoperative modified FOLFIRINOX (mFOLFIRINOX) followed by capecitabine-based chemoradiation (CRT) for borderline resectable (BLR) pancreatic cancer (PDAC): initial results from Alliance Trial A021101
- Journal / Conference
- Journal of Clinical Oncology Aug 20;33(24):2617-2622
- Year
- 2015
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID25964250
- PMC
- PMC4534524
- Study Number(s)
- S0809
SWOG S0809: A phase II intergroup trial of adjuvant capecitabine/gemcitabine followed by radiotherapy and concurrent capecitabine in extrahepatic cholangiocarcinoma and gallbladder carcinoma
- Journal / Conference
- Journal of Clinical Oncology 33:5s (suppl; abstr 7016); American Society of Clinical Oncology Annual Meeting (May 29-June 2, 2015, Chicago, IL), poster discussion;
- Year
- 2015
- Research Committee(s)
- Leukemia
- Study Number(s)
- S0535
Safety and tolerability of the combination of ATRA + Arsenic Trioxide (ATO) + Gemtuzumab Ozogamicin (GO) in high-risk acute promyelocytic leukemia (APL): initial report of the SWOG/Alliance/ECOG S0535 trial (NCT00551460)
- Journal / Conference
- Journal of Clinical Oncology J Clin Oncol 33:5s (suppl; abstr 7060); American Society of Clinical Oncology Annual Meeting (May 29-June 2, 2015, Chicago, IL), poster;
- Year
- 2015
- Research Committee(s)
- Leukemia
- Study Number(s)
- S0703
Association between early promoter-specific DNA methylation changes and outcome in older acute myeloid leukemia patients treated on SWOG S0703 (NCT00658814)
- Journal / Conference
- Journal of Clinical Oncology 33:5s (suppl; abstr TPS3627); American Society of Clinical Oncology Annual Meeting (May 29-June 2, 2015, Chicago, IL), poster session;
- Year
- 2015
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- Study Number(s)
- S0820
SWOG S0820/PACES (Preventing Adenomas of the Colon with Eflornithine and Sulindac), A Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Trial - NCT01349881
- Journal / Conference
- Journal of Clinical Oncology 33:5s (suppl; abstr TPS9093); American Society of Clinical Oncology Annual Meeting (May 29-June 2, 2015, Chicago, IL), poster session;
- Year
- 2015
- Research Committee(s)
- Melanoma
- Study Number(s)
- S1320
SWOG S1320: A randomized phase II trial of intermittent versus continuous dosing of dabrafenib and trametinib in BRAFV600E/K mutant melanoma
- Journal / Conference
- Journal of Clinical Oncology 33:5s (suppl; abstr TPS9085); American Society of Clinical Oncology Annual Meeting (May 29-June 2, 2015, Chicago, IL), poster session;
- Year
- 2015
- Research Committee(s)
- Melanoma
- Study Number(s)
- S1404
SWOG S1404: A phase III randomized trial comparing high dose interferon to MK-3475 (pembrolizumab) in patients with high risk resected melanoma
- Journal / Conference
- Journal of Clinical Oncology 33:5s (suppl; abstr e17084); American Society of Clinical Oncology Annual Meeting (May 29-June 2, 2015, Chicago, IL), publication only;
- Year
- 2015
- Research Committee(s)
- Brain
- Study Number(s)
- SWOG-9005
SWOG S9005: double blind phase III randomized trial of the anti-progestin agent mifepristone in the treatment of unresectable meningioma
- Journal / Conference
- Journal of Clinical Oncology 33:5s (suppl; abstr 5008); American Society of Clinical Oncology Annual Meeting (May 29-June 2, 2015, Chicago, IL), oral presentation;
- Year
- 2015
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-9346
Long term consequences of intermittent and continuous androgen deprivation in patients with metastatic prostate cancer
- Journal / Conference
- Journal of Clinical Oncology 33:5s (suppl; abstr LBA500); American Society of Clinical Oncology Annual Meeting (May 29-June 2, 2015, Chicago, IL), poster session;
- Year
- 2015
- Research Committee(s)
- Cancer Care Delivery